Vivani Medical Inc. (VANI) - Total Assets
Based on the latest financial reports, Vivani Medical Inc. (VANI) holds total assets worth $25.05 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See VANI book value for net asset value and shareholders' equity analysis.
Vivani Medical Inc. - Total Assets Trend (2012–2024)
This chart illustrates how Vivani Medical Inc.'s total assets have evolved over time, based on quarterly financial data.
Vivani Medical Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Vivani Medical Inc.'s total assets of $25.05 Million consist of 49.2% current assets and 50.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 44.2% |
| Accounts Receivable | $253.00K | 0.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Vivani Medical Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see VANI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vivani Medical Inc.'s current assets represent 49.2% of total assets in 2024, a decrease from 88.1% in 2012.
- Cash Position: Cash and equivalents constituted 44.2% of total assets in 2024, up from 1.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 0.6% of total assets.
Vivani Medical Inc. Competitors by Total Assets
Key competitors of Vivani Medical Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Vivani Medical Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.61 | 3.41 | 0.83 |
| Quick Ratio | 0.61 | 3.41 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.65 Million | $15.13 Million | $-863.00K |
Vivani Medical Inc. - Advanced Valuation Insights
This section examines the relationship between Vivani Medical Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 73.51 |
| Latest Market Cap to Assets Ratio | 2.31 |
| Asset Growth Rate (YoY) | -9.2% |
| Total Assets | $41.56 Million |
| Market Capitalization | $95.82 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Vivani Medical Inc.'s assets at a significant premium (2.31x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Vivani Medical Inc.'s assets decreased by 9.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Vivani Medical Inc. (2012–2024)
The table below shows the annual total assets of Vivani Medical Inc. from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $41.56 Million | -9.25% |
| 2023-12-31 | $45.80 Million | -10.43% |
| 2022-12-31 | $51.13 Million | +837.65% |
| 2021-12-31 | $5.45 Million | +4.52% |
| 2020-12-31 | $5.22 Million | -68.57% |
| 2019-12-31 | $16.60 Million | +55.39% |
| 2018-12-31 | $10.68 Million | -26.32% |
| 2017-12-31 | $14.50 Million | -13.77% |
| 2016-12-31 | $16.81 Million | -40.49% |
| 2015-12-31 | $28.25 Million | -34.41% |
| 2014-12-31 | $43.07 Million | +239.84% |
| 2013-12-31 | $12.67 Million | +58.56% |
| 2012-12-31 | $7.99 Million | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatid… Read more